This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawana, K.
Right arrow Articles by Kanda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawana, K.
Right arrow Articles by Kanda, T.

 Previous Article  |  Next Article 

Journal of Virology, December 1998, p. 10298-10300, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

In Vitro Construction of Pseudovirions of Human Papillomavirus Type 16: Incorporation of Plasmid DNA into Reassembled L1/L2 Capsids

Kei Kawana,1,2 Hiroyuki Yoshikawa,2 Yuji Taketani,2 Kunito Yoshiike,1 and Tadahito Kanda1,*

Division of Molecular Genetics, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo 162-8640,1 and Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033,2 Japan

Received 29 June 1998/Accepted 15 September 1998

Lack of permissive and productive cell cultures for the human papillomaviruses (HPVs) has hindered the study of virus-neutralizing antibodies and infection. We developed a cell-free system generating infectious HPV16 pseudovirions. HPV16 L1/L2 capsids, which had been self-assembled in insect cells (Sf9) expressing virion proteins L1 and L2, were disassembled with 2-mercaptoethanol (2-ME), a reducing agent, and reassembled by removal of 2-ME in the presence of a beta -galactosidase expression plasmid. Plasmid DNA purified together with the reassembled capsids was resistant to DNase I digestion. The reassembled pseudovirions mediated DNA transfer to COS-1 cells, as monitored by induced beta -galactosidase activity. Transfer was inhibited by anti-HPV16 L1 antiserum but not by antisera against L1s of HPV6 and HPV18. Construction in vitro of HPV pseudovirions containing marker plasmids would be potentially useful in developing methods to assay virus-neutralizing antibodies and to transfer exogenous genes to HPV-susceptible cells.


* Corresponding author. Mailing address: Division of Molecular Genetics, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan. Phone: 81-3-5285-1111, ext. 2524. Fax: 81-3-5285-1166. E-mail: kanda{at}nih.go.jp.


Journal of Virology, December 1998, p. 10298-10300, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Florin, L., Becker, K. A., Lambert, C., Nowak, T., Sapp, C., Strand, D., Streeck, R. E., Sapp, M. (2006). Identification of a Dynein interacting domain in the papillomavirus minor capsid protein l2.. J. Virol. 80: 6691-6696 [Abstract] [Full Text]  
  • Kamper, N., Day, P. M., Nowak, T., Selinka, H.-C., Florin, L., Bolscher, J., Hilbig, L., Schiller, J. T., Sapp, M. (2006). A Membrane-Destabilizing Peptide in Capsid Protein L2 Is Required for Egress of Papillomavirus Genomes from Endosomes. J. Virol. 80: 759-768 [Abstract] [Full Text]  
  • Huang, Y., Fayad, R., Smock, A., Ullrich, A. M., Qiao, L. (2005). Induction of Mucosal and Systemic Immune Responses against Human Carcinoembryonic Antigen by an Oral Vaccine. Cancer Res. 65: 6990-6999 [Abstract] [Full Text]  
  • Patterson, N. A., Smith, J. L., Ozbun, M. A. (2005). Human Papillomavirus Type 31b Infection of Human Keratinocytes Does Not Require Heparan Sulfate. J. Virol. 79: 6838-6847 [Abstract] [Full Text]  
  • Zhang, H., Fayad, R., Wang, X., Quinn, D., Qiao, L. (2004). Human Immunodeficiency Virus Type 1 Gag-Specific Mucosal Immunity after Oral Immunization with Papillomavirus Pseudoviruses Encoding Gag. J. Virol. 78: 10249-10257 [Abstract] [Full Text]  
  • Fayad, R., Zhang, H., Quinn, D., Huang, Y., Qiao, L. (2004). Oral Administration with Papillomavirus Pseudovirus Encoding IL-2 Fully Restores Mucosal and Systemic Immune Responses to Vaccinations in Aged Mice. J. Immunol. 173: 2692-2698 [Abstract] [Full Text]  
  • Florin, L., Becker, K. A., Sapp, C., Lambert, C., Sirma, H., Muller, M., Streeck, R. E., Sapp, M. (2004). Nuclear Translocation of Papillomavirus Minor Capsid Protein L2 Requires Hsc70. J. Virol. 78: 5546-5553 [Abstract] [Full Text]  
  • Buck, C. B., Pastrana, D. V., Lowy, D. R., Schiller, J. T. (2004). Efficient Intracellular Assembly of Papillomaviral Vectors. J. Virol. 78: 751-757 [Abstract] [Full Text]  
  • Yang, R., Yutzy, W. H. IV, Viscidi, R. P., Roden, R. B. S. (2003). Interaction of L2 with beta -Actin Directs Intracellular Transport of Papillomavirus and Infection. J. Biol. Chem. 278: 12546-12553 [Abstract] [Full Text]  
  • Yang, R., Day, P. M., Yutzy, W. H. IV, Lin, K.-Y., Hung, C.-F., Roden, R. B. S. (2003). Cell Surface-Binding Motifs of L2 That Facilitate Papillomavirus Infection. J. Virol. 77: 3531-3541 [Abstract] [Full Text]  
  • Bousarghin, L., Touze, A., Sizaret, P.-Y., Coursaget, P. (2003). Human Papillomavirus Types 16, 31, and 58 Use Different Endocytosis Pathways To Enter Cells. J. Virol. 77: 3846-3850 [Abstract] [Full Text]  
  • Bousarghin, L., Touze, A., Combita-Rojas, A.-L., Coursaget, P. (2003). Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor. J. Gen. Virol. 84: 157-164 [Abstract] [Full Text]  
  • Combita, A.-L., Touze, A., Bousarghin, L., Christensen, N. D., Coursaget, P. (2002). Identification of Two Cross-Neutralizing Linear Epitopes within the L1 Major Capsid Protein of Human Papillomaviruses. J. Virol. 76: 6480-6486 [Abstract] [Full Text]  
  • Bousarghin, L., Combita-Rojas, A.-L., Touze, A., El Mehdaoui, S., Sizaret, P.-Y., Bravo, M.-M., Coursaget, P. (2002). Detection of Neutralizing Antibodies against Human Papillomaviruses (HPV) by Inhibition of Gene Transfer Mediated by HPV Pseudovirions. J. Clin. Microbiol. 40: 926-932 [Abstract] [Full Text]  
  • Shi, W., Liu, J., Huang, Y., Qiao, L. (2001). Papillomavirus Pseudovirus: a Novel Vaccine To Induce Mucosal and Systemic Cytotoxic T-Lymphocyte Responses. J. Virol. 75: 10139-10148 [Abstract] [Full Text]  
  • Fligge, C., Schafer, F., Selinka, H.-C., Sapp, C., Sapp, M. (2001). DNA-Induced Structural Changes in the Papillomavirus Capsid. J. Virol. 75: 7727-7731 [Abstract] [Full Text]  
  • Kawana, Y., Kawana, K., Yoshikawa, H., Taketani, Y., Yoshiike, K., Kanda, T. (2001). Human Papillomavirus Type 16 Minor Capsid Protein L2 N-Terminal Region Containing a Common Neutralization Epitope Binds to the Cell Surface and Enters the Cytoplasm. J. Virol. 75: 2331-2336 [Abstract] [Full Text]  
  • Giroglou, T., Florin, L., Schäfer, F., Streeck, R. E., Sapp, M. (2001). Human Papillomavirus Infection Requires Cell Surface Heparan Sulfate. J. Virol. 75: 1565-1570 [Abstract] [Full Text]  
  • Ishizu, K.-I., Watanabe, H., Han, S.-I., Kanesashi, S.-N., Hoque, M., Yajima, H., Kataoka, K., Handa, H. (2001). Roles of Disulfide Linkage and Calcium Ion-Mediated Interactions in Assembly and Disassembly of Virus-Like Particles Composed of Simian Virus 40 VP1 Capsid Protein. J. Virol. 75: 61-72 [Abstract] [Full Text]  
  • El Mehdaoui, S., Touzé, A., Laurent, S., Sizaret, P.-Y., Rasschaert, D., Coursaget, P. (2000). Gene Transfer Using Recombinant Rabbit Hemorrhagic Disease Virus Capsids with Genetically Modified DNA Encapsidation Capacity by Addition of Packaging Sequences from the L1 or L2 Protein of Human Papillomavirus Type 16. J. Virol. 74: 10332-10340 [Abstract] [Full Text]  
  • Kawana, K., Yoshikawa, H., Taketani, Y., Yoshiike, K., Kanda, T. (1999). Common Neutralization Epitope in Minor Capsid Protein L2 of Human Papillomavirus Types 16 and 6. J. Virol. 73: 6188-6190 [Abstract] [Full Text]